Table 3. Determining factors for brachial-ankle pulse wave velocity in hemodialysis patients with residual renal function.

	Univariate model			Multivariate model
	Beta	standard error	p-value	Beta	standard error	p-value
Age (y)	-0.01	2.61	0.98	0.01	2.56	0.94
Male (vs. female)	0.05	56.99	0.61
Initial end-stage renal disease (Diabetes vs. non-diabetes)	0.39	53.00	<0.001	0.38	54.14	<0.001
Log-duration of hemodialysis (months)	-0.09	120.78	0.38	-0.10	113.61	0.28
Mean interdialytic weight gain (kg)	0.20	24.80	0.05	0.13	24.44	0.18
Log-KRU (mL/min/1.73m2)	-0.25	50.21	0.01	-0.19	52.24	0.05
Use of vitamin D analogs	0.11	58.86	0.27
Use of calcium-based phosphate binders	0.16	58.12	0.10
Log-(Ca × P) (mg2/dL2)	-0.16	150.38	0.12
Log-CRP (mg/L)	-0.16	54.92	0.11
Log-Parathyroid hormone (pg/dL)	0.02	71.36	0.82
β2-Microglobulin (mg/L)	0.08	4.38	0.42

Abbreviations: Ca × P; Calcium × Phosphate; CRP, C-reactive protein; KRU, residual renal urea clearance.